中国科学院机构知识库网格系统: 检索

浏览/检索结果: 共5条，第1-5条

帮助

条数/页：排序方式：
	Preclinical evaluation of 3D185, a novel potent inhibitor of FGFR1/2/3 and CSF-1R, in FGFR-dependent and macrophage-dominant cancer models. 期刊论文 OAI收割 CANCER IMMUNOLOGY RESEARCH, 2020, 卷号: 8, 期号: 3, 页码: 70-70 作者: Dai, Yang; Ji, Yichun; Shen, Yanyan; Su, Yi; Liu, Bo \| 收藏 \| 浏览/下载：43/0 \| 提交时间：2020/07/01
	Preclinical evaluation of 3D185, a novel potent inhibitor of FGFR1/2/3 and CSF-1R, in FGFR-dependent and macrophage-dominant cancer models 期刊论文 OAI收割 JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2019, 卷号: 38, 期号: 1, 页码: 16 作者: Peng, Xia; Hou, Pengcong; Chen, Yi; Dai, Yang; Ji, Yinchun \| 收藏 \| 浏览/下载：38/0 \| 提交时间：2020/07/01 Kinase inhibitor FGFR CSF-1R Tumor microenvironment
	Preclinical evaluation of 3D185, a novel potent inhibitor of FGFR1 期刊论文 OAI收割 Journal of Experimental & Clinical Cancer Research, 2019, 卷号: 38, 期号: 1 作者: Xia Peng; Pengcong Hou; Yi Chen; Yang Dai; Yinchun Ji \| 收藏 \| 浏览/下载：22/0 \| 提交时间：2021/12/01
	Design, synthesis and biological evaluation of tetrahydronaphthyridine derivatives as bioavailable CDK4/6 inhibitors for cancer therapy 期刊论文 OAI收割 EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2018, 卷号: 148, 页码: 140-153 作者: Zha, Chuantao; Deng, Wenjia; Fu, Yan; Tang, Shuai; Lan, Xiaojing \| 收藏 \| 浏览/下载：79/0 \| 提交时间：2019/01/08 Structure-based drug design Selective CDK4/6 inhibitors Structure-activity relationship study In vivo antitumor activity
	Discovery of a class of diheteroaromatic amines as orally bioavailable CDK1/4/6 inhibitors 期刊论文 OAI收割 BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2017, 卷号: 27, 期号: 23, 页码: 5332-5336 作者: Fu, Yan; Tang, Shuai; Su, Yi; Lan, Xiaojing; Ye, Yan \| 收藏 \| 浏览/下载：35/0 \| 提交时间：2019/01/08 Cyclin-dependent kinase CDK inhibitor Structure-activity relationship In vitro and in vivo profiling